Vir Biotechnology, Inc.
VIR
$5.63
-$0.44-7.25%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -80.23% | -59.96% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -80.23% | -59.96% | |||
| Cost of Revenue | 55.30% | -17.09% | |||
| Gross Profit | -57.01% | 15.95% | |||
| SG&A Expenses | -0.23% | -6.94% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 44.97% | -15.37% | |||
| Operating Income | -46.26% | 14.39% | |||
| Income Before Tax | -47.10% | 8.40% | |||
| Income Tax Expenses | -1.18% | 962.50% | |||
| Earnings from Continuing Operations | -47.03% | 8.27% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -47.03% | 8.27% | |||
| EBIT | -46.26% | 14.39% | |||
| EBITDA | -47.35% | 14.73% | |||
| EPS Basic | -46.53% | 8.92% | |||
| Normalized Basic EPS | -52.22% | 15.44% | |||
| EPS Diluted | -46.53% | 8.92% | |||
| Normalized Diluted EPS | -52.22% | 15.44% | |||
| Average Basic Shares Outstanding | 0.35% | 0.71% | |||
| Average Diluted Shares Outstanding | 0.35% | 0.71% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||